The RSI Oscillator for PTGX moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 18 of the 22 cases the stock moved higher. This puts the odds of a move higher at 82%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 58 cases where PTGX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
Following a +3.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTGX advanced for three days, in 231 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
PTGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTGX as a result. In 67 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.
The Moving Average Convergence Divergence Histogram (MACD) for PTGX turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 35 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 69%.
PTGX moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTGX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. PTGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 67 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.153) is normal, around the industry mean (3.498). PTGX has a moderately high P/E Ratio (108.230) as compared to the industry average of (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (34.130) is also within normal values, averaging (440.869).
TARS moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 84%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TARS as a result. In 66 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for TARS just turned positive on November 10, 2026. Looking at past instances where TARS's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
Following a +8.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where TARS advanced for three days, in 230 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 10-day moving average for TARS crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TARS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
TARS broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TARS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.258) is normal, around the industry mean (3.498). TARS has a moderately low P/E Ratio (-64.112) as compared to the industry average of (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (5.498) is also within normal values, averaging (440.869).
The Tickeron Seasonality Score of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 48 (best 1 - 100 worst), indicating steady price growth. TARS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
PTGX | TARS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 97 Overvalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 5 | 22 | |
SMR RATING 1..100 | 59 | 94 | |
PRICE GROWTH RATING 1..100 | 45 | 48 | |
P/E GROWTH RATING 1..100 | 67 | 75 | |
SEASONALITY SCORE 1..100 | 50 | 17 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TARS's Valuation (3) in the null industry is significantly better than the same rating for PTGX (97) in the Biotechnology industry. This means that TARS’s stock grew significantly faster than PTGX’s over the last 12 months.
PTGX's Profit vs Risk Rating (5) in the Biotechnology industry is in the same range as TARS (22) in the null industry. This means that PTGX’s stock grew similarly to TARS’s over the last 12 months.
PTGX's SMR Rating (59) in the Biotechnology industry is somewhat better than the same rating for TARS (94) in the null industry. This means that PTGX’s stock grew somewhat faster than TARS’s over the last 12 months.
PTGX's Price Growth Rating (45) in the Biotechnology industry is in the same range as TARS (48) in the null industry. This means that PTGX’s stock grew similarly to TARS’s over the last 12 months.
PTGX's P/E Growth Rating (67) in the Biotechnology industry is in the same range as TARS (75) in the null industry. This means that PTGX’s stock grew similarly to TARS’s over the last 12 months.
| PTGX | TARS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | N/A |
| Stochastic ODDS (%) | 1 day ago 71% | 1 day ago 82% |
| Momentum ODDS (%) | 1 day ago 71% | 1 day ago 80% |
| MACD ODDS (%) | 1 day ago 69% | 1 day ago 84% |
| TrendWeek ODDS (%) | 1 day ago 75% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 79% |
| Advances ODDS (%) | 2 days ago 76% | 1 day ago 81% |
| Declines ODDS (%) | 6 days ago 76% | 7 days ago 83% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 82% |
| Aroon ODDS (%) | N/A | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PTGX’s FA Score shows that 1 FA rating(s) are green while TARS’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PTGX’s TA Score shows that 4 TA indicator(s) are bullish while TARS’s TA Score has 4 bullish TA indicator(s).
PTGX (@Biotechnology) experienced а -5.94% price change this week, while TARS (@Biotechnology) price change was +11.13% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.
PTGX is expected to report earnings on Mar 02, 2027.
TARS is expected to report earnings on Mar 02, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, PTGX has been loosely correlated with MGTX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PTGX jumps, then MGTX could also see price increases.
| Ticker / NAME | Correlation To PTGX | 1D Price Change % | ||
|---|---|---|---|---|
| PTGX | 100% | -1.03% | ||
| MGTX - PTGX | 51% Loosely correlated | +0.62% | ||
| DYN - PTGX | 49% Loosely correlated | +0.39% | ||
| DNTH - PTGX | 47% Loosely correlated | +0.55% | ||
| ARQT - PTGX | 46% Loosely correlated | +3.63% | ||
| IMVT - PTGX | 46% Loosely correlated | +3.72% | ||
More | ||||
A.I.dvisor indicates that over the last year, TARS has been loosely correlated with PTGX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then PTGX could also see price increases.
| Ticker / NAME | Correlation To TARS | 1D Price Change % | ||
|---|---|---|---|---|
| TARS | 100% | +3.97% | ||
| PTGX - TARS | 45% Loosely correlated | -1.03% | ||
| ARVN - TARS | 40% Loosely correlated | -0.14% | ||
| MGTX - TARS | 40% Loosely correlated | +0.62% | ||
| SVRA - TARS | 39% Loosely correlated | +1.42% | ||
| BLTE - TARS | 39% Loosely correlated | -0.37% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| COZX | 4.93 | 0.91 | +22.64% |
| Tradr 2X Long CORZ Daily ETF (COZX) | |||
| SGRW | 25.37 | 0.42 | +1.67% |
| Harbor Active Small Cap Growth ETF | |||
| HAWX | 45.24 | 0.60 | +1.34% |
| iShares Currency Hedged MSCI ACWI ex U.S. ETF (HAWX) | |||
| DHS | 120.06 | 0.64 | +0.54% |
| WisdomTree U.S. High Dividend Fund (DHS) | |||
| GMOV | 33.31 | 0.06 | +0.18% |
| GMO US Value ETF | |||